MAIA Biotechnology: director Guerrero Ramiro received 32,012 shares

What happened

• The filing reports that Guerrero Ramiro, a director, received a grant of 32,012 shares (derivative) on Sep 30, 2026 at an acquisition price of $0.00 (total $0), reported as transaction type A (award/grant).

Key details

• Transaction date and price: Sep 30, 2026; acquisition price $0.00.
• Shares acquired: 32,012 (derivative/security type: stock options per footnote).
• Shares owned after the transaction: not stated in the filing provided.
• Footnote: the stock options, granted under MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, vest 100% on the date of the grant and are exercisable beginning as of that date.
• Filing timeliness: not indicated in the information provided.

Why it may matter

• This was a grant of stock options (a derivative award), not a market purchase or sale.
• A filing does not show why the insider traded or why the company acted.